메뉴 건너뛰기




Volumn 15, Issue 3, 2011, Pages 373-380

Steroids and azathioprine in the treatment of IgA nephropathy

Author keywords

Azathioprine; IgAN; Proteinuria; Steroids; Treatment

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; METHYLPREDNISOLONE; POLYUNSATURATED FATTY ACID; PREDNISOLONE;

EID: 79959282580     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0415-3     Document Type: Article
Times cited : (20)

References (27)
  • 1
    • 38349090465 scopus 로고    scopus 로고
    • Natural history of primary IgA nephropathy
    • Berthoux FC, Mohey H, Afiani A. Natural history of primary IgA nephropathy. Semin Nephrol. 2008;28:4-9.
    • (2008) Semin Nephrol , vol.28 , pp. 4-9
    • Berthoux, F.C.1    Mohey, H.2    Afiani, A.3
  • 2
    • 51349098242 scopus 로고    scopus 로고
    • IgA nephropathy: Challenges and opportunities
    • Glassock RJ. IgA nephropathy: challenges and opportunities. Cleve Clin J Med. 2008;75:569-76.
    • (2008) Cleve Clin J Med , vol.75 , pp. 569-576
    • Glassock, R.J.1
  • 3
    • 68949206247 scopus 로고    scopus 로고
    • The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility
    • Working Group of the International IgA Nephropathy Network and the Renal Pathology Society
    • Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76:546-56.
    • (2009) Kidney Int , vol.76 , pp. 546-556
    • Roberts, I.S.1    Cook, H.T.2    Troyanov, S.3
  • 4
    • 0347362489 scopus 로고    scopus 로고
    • Treatment of primary IgA nephrophty
    • Alexopoulos E. Treatment of primary IgA nephrophty. Kidney Int. 2004;64:341-56.
    • (2004) Kidney Int , vol.64 , pp. 341-356
    • Alexopoulos, E.1
  • 6
    • 71049125647 scopus 로고    scopus 로고
    • Randomized controlled clinical trial of corticosteroids plus ACEinhibitors with long-term follow-up in proteinuric IgA nephropathy
    • Manno C, Torres DD, Rossini M, Pesce F, Schena FP. Randomized controlled clinical trial of corticosteroids plus ACEinhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant. 2009;24:3694-701.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 3694-3701
    • Manno, C.1    Torres, D.D.2    Rossini, M.3    Pesce, F.4    Schena, F.P.5
  • 8
    • 0036139035 scopus 로고    scopus 로고
    • Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy
    • Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol. 2002;13:142-8. (Pubitemid 34042021)
    • (2002) Journal of the American Society of Nephrology , vol.13 , Issue.1 , pp. 142-148
    • Ballardie, F.W.1    Roberts, I.S.D.2
  • 10
    • 0036045191 scopus 로고    scopus 로고
    • Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria
    • DOI 10.1023/A:1014424723466
    • Harmankaya O, Oztürk Y, Baştürk T, Obek A, Kiliçarslan I. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria. Int Urol Nephrol. 2002;33:167-71. (Pubitemid 34575432)
    • (2001) International Urology and Nephrology , vol.33 , Issue.1 , pp. 167-171
    • Harmankaya, O.1    Ozturk, Y.2    Basturk, T.3    Obek, A.4    Kilicarslan, I.5
  • 11
    • 33751404292 scopus 로고    scopus 로고
    • Steroid treatment for severe childhood IgA nephropathy: A randomized, controlled trial
    • Japanese Pediatric IgA Nephropathy Treatment Study Group
    • Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H, Japanese Pediatric IgA Nephropathy Treatment Study Group. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol. 2006;1:511-7.
    • (2006) Clin J Am Soc Nephrol , vol.1 , pp. 511-517
    • Yoshikawa, N.1    Honda, M.2    Iijima, K.3    Awazu, M.4    Hattori, S.5    Nakanishi, K.6    Ito, H.7
  • 13
    • 33751419293 scopus 로고    scopus 로고
    • IgA nephritis: ACE inhibitors, steroids, both or neither?
    • Locatelli F, Pozzi C, Andrulli S. IgA nephritis: ACE inhibitors, steroids, both or neither? Nephrol Dial Transplant. 2006;21: 3357-61.
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 3357-3361
    • Locatelli, F.1    Pozzi, C.2    Andrulli, S.3
  • 15
    • 0030031995 scopus 로고    scopus 로고
    • Vasoactive hormones and renal sclerosis
    • Egido J. Vasoactive hormones and renal sclerosis. Kidney Int. 1996;49:578-97. (Pubitemid 26051838)
    • (1996) Kidney International , vol.49 , Issue.2 , pp. 578-597
    • Egido, J.1
  • 16
    • 4444346216 scopus 로고    scopus 로고
    • Treatment of severe IgA nephropathy with omega-3 fatty acids: The effect of a "very low dose" regimen
    • Alexopoulos E, Stangou M, Pantzaki A, Kirmizis D, Memmos D. Treatment of severe IgA nephropathy with omega-3 fatty acids: the effect of a "very low dose" regimen. Ren Fail. 2004;26:453-9.
    • (2004) Ren Fail , vol.26 , pp. 453-459
    • Alexopoulos, E.1    Stangou, M.2    Pantzaki, A.3    Kirmizis, D.4    Memmos, D.5
  • 19
    • 69449092837 scopus 로고    scopus 로고
    • Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy
    • Stangou M, Alexopoulos E, Papagianni A, et al. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy. Nephrology. 2009;14:613-20.
    • (2009) Nephrology , vol.14 , pp. 613-620
    • Stangou, M.1    Alexopoulos, E.2    Papagianni, A.3
  • 20
    • 51649113133 scopus 로고    scopus 로고
    • C5b-9 glomerular deposition and tubular alpha3beta1-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy
    • Stangou M, Alexopoulos E, Pantzaki A, Leonstini M, Memmos D. C5b-9 glomerular deposition and tubular alpha3beta1-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy. Scand J Urol Nephrol. 2008;42:373-80.
    • (2008) Scand J Urol Nephrol , vol.42 , pp. 373-380
    • Stangou, M.1    Alexopoulos, E.2    Pantzaki, A.3    Leonstini, M.4    Memmos, D.5
  • 22
    • 0038352217 scopus 로고    scopus 로고
    • Prednisolone and azathioprine in IgA nephropathy: A ten-year follow-up study
    • Goumenos DS, Davlouros P, El Nahas AM, et al. Prednisolone and azathioprine in IgA nephropathy: a ten-year follow-up study. Nephron Clin Pract. 2003;93:58-68.
    • (2003) Nephron Clin Pract , vol.93 , pp. 58-68
    • Goumenos, D.S.1    Davlouros, P.2    El Nahas, A.M.3
  • 25
    • 77949542202 scopus 로고    scopus 로고
    • Long-term study of mycophenolate mofetil treatment in IgA nephropathy
    • Tang SC, Tang AW, Wong SS, Leung JC, Ho YW, Lai KN. Long-term study of mycophenolate mofetil treatment in IgA nephropathy. Kidney Int. 2010;77(6):543-9.
    • (2010) Kidney Int , vol.77 , Issue.6 , pp. 543-549
    • Tang, S.C.1    Tang, A.W.2    Wong, S.S.3    Leung, J.C.4    Ho, Y.W.5    Lai, K.N.6
  • 27
    • 0037172742 scopus 로고    scopus 로고
    • A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy
    • Chen X, Chen P, Cai G, et al. A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy. Zhonghua Yi Xue Za Zhi. 2002;82:796-801.
    • (2002) Zhonghua Yi Xue Za Zhi , vol.82 , pp. 796-801
    • Chen, X.1    Chen, P.2    Cai, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.